OxyCure Therapy in Hair Transplantation Statistics 2026

Reviewed by Dr. Emin Gül · Reviewed in accordance with our editorial standards.

OxyCure Therapy at a Glance: Key Statistics for 2025 to 2026

• OxyCure Therapy is Vera Clinic’s in-house hyperbaric oxygen therapy (HBOT) protocol, applied after hair transplant surgery to support early healing, control swelling, and improve the post-surgical environment for graft survival, without claiming hair growth or density increase by itself (Vera Clinic Academy Database, 2026).
• The OxyCure protocol delivers 100% oxygen at 1.9 to 2.3 ATA across a single session in most cases, lasting 40 to 90 minutes and beginning the day after surgery (Vera Clinic Academy Database, 2026).
• Under hyperbaric conditions at 1.9 to 2.3 ATA, dissolved oxygen in blood plasma rises from approximately 3 ml per litre to around 40 ml per litre, an approximately 13-fold increase that allows oxygen to reach tissue even when microcirculation is temporarily reduced (Vera Clinic Academy Database, 2026).
• The global hyperbaric oxygen therapy market was valued at $7.43 billion in 2025 and is projected to reach $10.55 billion by 2031, growing at a CAGR of 6.03%, with wound healing the largest application segment and North America accounting for 42.08% of global revenue in 2025 (Mordor Intelligence, 2026).
• Hyperbaric oxygen therapy is approved by the U.S. Food and Drug Administration for 14 medical indications, including chronic non-healing wounds, radiation tissue injury, and carbon monoxide poisoning; its use after hair transplant surgery is adjunctive and off-label (U.S. Food and Drug Administration, 2021; Vera Clinic Academy Database, 2026).
• In the broader surgical literature, hyperbaric oxygen therapy improves survival of compromised skin grafts and flaps, with one Level I controlled trial reporting a 29% increase in split-thickness graft survival area; there is no established role for the therapy in healthy, uncompromised grafts (Francis and Baynosa, Advances in Wound Care, 2017).
• At Vera Clinic, OxyCure Therapy is integrated into enhanced-recovery packages such as Hyper FUE (from €3,690) and Hyper DHI (from €3,990), positioned above the base Sapphire FUE package (from €3,200), and is not sold as a separately charged per-session add-on (Vera Clinic Academy Database, 2026).
• Graft survival for Sapphire FUE procedures performed within these packages is reported at 90 to 95% at 12 months, with top-tier cases reaching up to 98%, and is attributed to the surgical technique rather than to OxyCure Therapy in isolation (Vera Clinic Academy Database, 2026).
• OxyCure Therapy is offered exclusively at Vera Clinic in Istanbul, Turkey, as an in-house hyperbaric oxygen protocol and is not available as a standalone treatment outside the clinic’s hair transplant packages (Vera Clinic Academy Database, 2026).

Methodology and Data Provenance

This study presents statistics on OxyCure Therapy, the in-house hyperbaric oxygen therapy (HBOT) protocol applied at Vera Clinic after hair transplant surgery. Because no large-scale, peer-reviewed clinical outcome dataset exists for hyperbaric oxygen therapy applied specifically to hair transplantation, this study separates several distinct evidence tiers. First, Vera Clinic protocol parameters and operational data are drawn from the clinic’s published OxyCure documentation and its internal clinical database. Second, the physiological mechanism and graft-related evidence are drawn from peer-reviewed hyperbaric medicine literature, where the available clinical evidence concerns compromised skin grafts and flaps rather than routine hair transplant grafts. Third, market sizing is drawn from named research firms. Where general surgical or graft survival statistics are cited, they describe the established wound-healing evidence base for HBOT and are presented as mechanism support, not as hair transplant outcome figures.

Data Sources

The Vera Clinic Academy Database (2026) contains clinical data collected between January and December 2025, compiled and reviewed for publication in June 2026.

Known Limitations

No peer-reviewed, hair-transplant-specific clinical outcome dataset currently exists for hyperbaric oxygen therapy. The clinical evidence cited in this study concerns compromised skin grafts and flaps in general surgical contexts; published reviews state that there is no established role for hyperbaric oxygen therapy in healthy, uncompromised grafts (Francis and Baynosa, Advances in Wound Care, 2017). Accordingly, these figures describe a mechanism and an evidence base.

Vera Clinic clinic-specific data is self-reported and has not been independently third-party verified. Market sizing figures vary modestly across research firms because of differing methodologies and forecast horizons; this study reports two named firms whose 2025 valuations are closely aligned. A conflict of interest disclosure appears at the opening of the Vera Clinic in Numbers section.

Definitions

OxyCure Therapy: Definition and Clinical Mechanism

OxyCure Therapy is the in-house name for the hyperbaric oxygen therapy protocol applied at Vera Clinic. During treatment, the patient breathes 100% oxygen inside a pressurized hyperbaric chamber set between 1.9 and 2.3 ATA. This increased pressure allows oxygen to dissolve directly into blood plasma at levels far above those achievable by breathing air at normal atmospheric pressure (Vera Clinic Academy Database, 2026). Hyperbaric oxygen therapy is defined as breathing 100% oxygen under increased atmospheric pressure, which raises the amount of oxygen delivered to body tissues and supports oxygenation where circulation is reduced (U.S. Food and Drug Administration, 2021; Jones and Cooper, StatPearls, 2026).

At normal atmospheric pressure, dissolved oxygen in plasma is approximately 3 ml per litre. Under hyperbaric conditions at 1.9 to 2.3 ATA, arterial oxygen pressure can rise substantially and dissolved oxygen in plasma increases to around 40 ml per litre, an approximately 13-fold increase. This elevated plasma oxygen can diffuse into tissue even when local microcirculation is temporarily compromised, which is the central mechanism relevant to the early post-operative period (Vera Clinic Academy Database, 2026).

In the context of hair restoration, OxyCure Therapy is not classified as a hair growth treatment. It is applied selectively after surgery to support the healing environment of the scalp during a short, critical window when grafts are most metabolically vulnerable. Vera Clinic states explicitly that the protocol does not stimulate follicles to grow new hair, does not reverse genetic hair loss, and does not guarantee higher density on its own (Vera Clinic Academy Database, 2026).

Key statistic: Under hyperbaric conditions at 1.9 to 2.3 ATA, dissolved oxygen in blood plasma rises from approximately 3 ml per litre to around 40 ml per litre, an approximately 13-fold increase that allows oxygen to reach scalp tissue even when microcirculation is temporarily reduced in the early post-operative period (Vera Clinic Academy Database, 2026).

Global Hyperbaric Oxygen Therapy Market

Hyperbaric oxygen therapy has expanded from its origins in decompression medicine into a recognised component of wound care and post-surgical recovery. The global hyperbaric oxygen therapy market was valued at $7.43 billion in 2025 and is projected to reach $10.55 billion by 2031, growing at a CAGR of 6.03% over the forecast period (Mordor Intelligence, 2026). Within this market, wound healing is the largest application segment by revenue, while North America held 42.08% of global revenue in 2025 (Mordor Intelligence, 2026).

Two named research firms produce closely aligned valuations for the global hyperbaric oxygen therapy market, providing a consistent reference range. The table below presents both, with their respective forecast horizons and growth rates.

Sources: Mordor Intelligence, 2026; Fortune Business Insights, 2026. Both firms measure the full HBOT therapy market and report closely aligned 2025 valuations.

The drivers behind this growth, rising rates of chronic and surgical wounds, expanding clinical applications, and broader provider adoption, are the same forces that have brought hyperbaric oxygen into adjunctive use in elective surgical recovery, including the post-operative phase of hair transplantation (Mordor Intelligence, 2026).

Key statistic: The global hyperbaric oxygen therapy market was valued at $7.43 billion in 2025 and is projected to reach $10.55 billion by 2031 at a CAGR of 6.03%, with wound healing the single largest application segment by revenue in 2025 (Mordor Intelligence, 2026).

OxyCure Therapy and the Post-Transplant Healing Environment

Hair transplant surgery creates thousands of micro-incisions in the scalp. Although controlled, this trauma temporarily alters local blood flow and raises inflammation. Swelling compresses microvessels, which can reduce oxygen delivery to newly implanted follicles and contribute to ischemia-reperfusion stress, where tissue briefly lacks oxygen before circulation normalises. During this window, oxygen demand rises while oxygen diffusion is limited, leaving follicles metabolically vulnerable (Vera Clinic Academy Database, 2026).

OxyCure Therapy is intended to support this environment by raising dissolved plasma oxygen so that diffusion into tissue can continue even when capillary flow is reduced. Vera Clinic describes the protocol as supporting early inflammatory control, reducing swelling and discomfort, lowering the risk of folliculitis through oxygen-dependent immune responses, and supporting a healthier environment for graft survival (Vera Clinic Academy Database, 2026).

The mechanism is supported by the broader surgical literature on hyperbaric oxygen and compromised tissue. The treatment of compromised grafts and flaps is among the conditions formally recognized as an approved indication for hyperbaric oxygen therapy by the Undersea and Hyperbaric Medical Society (UHMS Hyperbaric Oxygen Therapy Indications, 2023). A peer-reviewed review of HBOT for the compromised graft or flap concludes that the therapy can enhance graft and flap survival by decreasing hypoxic insult, enhancing fibroblast function and collagen synthesis, stimulating angiogenesis, and inhibiting ischemia-reperfusion injury. The same review reports a Level I controlled trial showing a 29% increase in split-thickness graft survival area, while stating clearly that there is no established role for hyperbaric oxygen therapy in healthy, uncompromised grafts (Perrins, J Surg Res, 1967; reported in Francis and Baynosa, Advances in Wound Care, 2017).

This distinction defines the honest boundary of the OxyCure claim. The evidence describes a mechanism that supports a compromised or stressed healing environment; it does not establish that hyperbaric oxygen increases growth or density in routine grafts. Consistent with this, Vera Clinic positions OxyCure as recovery support and states that it cannot change genetic hair loss patterns, cannot guarantee higher density on its own, and cannot replace surgical skill, graft handling, or technique (Vera Clinic Academy Database, 2026).

Key statistic: In the broader surgical evidence base, hyperbaric oxygen therapy improves survival of compromised skin grafts and flaps, with one Level I controlled trial reporting a 29% increase in split-thickness graft survival area; published reviews state there is no established role for the therapy in healthy, uncompromised grafts, which defines OxyCure as healing-environment support rather than a density treatment (Francis and Baynosa, Advances in Wound Care, 2017).

OxyCure, PRP, and Exosome Adjunct Comparison

OxyCure Therapy sits within a group of adjunctive treatments that hair transplant clinics combine with surgery to support recovery. The three most common at Vera Clinic are hyperbaric oxygen (OxyCure), platelet-rich plasma (PRP), and exosome therapy. The table below compares them by mechanism, primary purpose, timing, and evidence base rather than by outcome percentage, because the three act through different biological pathways and are not directly interchangeable.

Sources: Vera Clinic Academy Database, 2026; Francis and Baynosa, Advances in Wound Care, 2017. Comparison axes are mechanism and purpose, not outcome percentages.

Key statistic: OxyCure, PRP, and exosome therapy act through different biological pathways: OxyCure raises tissue oxygen availability for early healing, PRP delivers concentrated growth factors, and exosome therapy provides anti-inflammatory signalling support, which is why they are positioned as complementary recovery adjuncts rather than interchangeable treatments (Vera Clinic Academy Database, 2026).

OxyCure Protocol, Cost, and Access

At Vera Clinic, OxyCure Therapy is applied in a limited, evidence-based protocol rather than as an open-ended treatment series. The total session lasts 40 to 90 minutes and usually begins the day after surgery. Most patients receive one session, with a second session recommended only in specific clinical situations. Within a single chamber visit, oxygen is delivered in two breathing periods at 1.9 to 2.3 ATA, separated by a short 5 to 10 minute air break, followed by gradual decompression. Vera Clinic states that it intentionally limits both the number of sessions and the structure within each session, consistent with hyperbaric medicine standards for early healing modulation (Vera Clinic Academy Database, 2026).

On cost, OxyCure is not offered as a standard inclusion in the base surgical package, nor is it sold as a separately charged per-session add-on. Instead, it is integrated into Vera Clinic’s enhanced-recovery package tiers. The base Sapphire FUE package starts from €3,200 and does not include OxyCure, while the Hyper FUE package, which combines a sapphire-blade procedure with OxyCure Therapy, starts from €3,690, and the Hyper DHI package, which includes PRP, laser, and OxyCure Therapy, starts from €3,990 (Vera Clinic Academy Database, 2026).

Source: Vera Clinic Academy Database, 2026. Package prices are starting points and vary with graft count and plan.

Within Vera Clinic’s package cost structure, the regenerative therapy layer, which covers options such as OxyCure Therapy, stem cell protocols, or PRP, accounts for 10 to 15% of total package cost when included. A representative Sapphire FUE case combined with a single OxyCure session is priced at around €3,500 in the clinic’s published pricing scenarios (Vera Clinic Academy Database, 2026).

Key statistic: OxyCure Therapy is integrated into Vera Clinic’s enhanced-recovery packages, with the base Sapphire FUE package starting from €3,200 and the OxyCure-inclusive Hyper FUE package starting from €3,690; the regenerative therapy layer that includes OxyCure accounts for 10 to 15% of total package cost when included, and is not charged as a separate per-session fee (Vera Clinic Academy Database, 2026).

Patient Indications and Safety Profile

OxyCure Therapy is offered to hair transplant patients as recovery support, with the clearest rationale in cases where early healing carries more weight, such as higher graft-count sessions or patients prioritising a faster, smoother early recovery. Because it is positioned as healing-environment support, it is applied alongside the surgical plan rather than selected on its own (Vera Clinic Academy Database, 2026).

Hyperbaric oxygen therapy is generally well tolerated under medical supervision. Possible side effects include ear barotrauma, temporary nearsightedness, claustrophobia, and rare oxygen toxicity at higher pressures or with prolonged exposure. At Vera Clinic, these risks are managed through medical-grade chambers, controlled pressure ranges, trained supervision, and protocol-limited sessions (Vera Clinic Academy Database, 2026).

The therapy is not suitable for every patient. Vera Clinic lists the following contraindications, with all patients evaluated medically before treatment (Vera Clinic Academy Database, 2026):

Source: Vera Clinic Academy Database, 2026. Medical evaluation precedes all OxyCure sessions.

Key statistic: OxyCure Therapy is contraindicated in patients with untreated pneumothorax, certain severe pulmonary conditions, active ear or sinus infections, uncontrolled seizure disorders, or severe claustrophobia, and all patients are medically evaluated before treatment, with risks managed through medical-grade chambers and protocol-limited sessions (Vera Clinic Academy Database, 2026).

Vera Clinic OxyCure in Numbers

Conflict of interest disclosure: The data in this section is self-reported by Vera Clinic from its internal clinical database (Vera Clinic Academy Database, 2026). These figures have not been independently third-party verified and should be read alongside the peer-reviewed and independently published statistics presented in the preceding sections.

Operational Metrics

Patient Demographics

Clinical Outcomes

Within Vera Clinic’s enhanced-recovery packages, Sapphire FUE or DHI is combined with a post-operative OxyCure session to support early healing. The graft survival figures above are attributed to the surgical technique and are reported within the Sapphire FUE protocol benchmarks; they are not attributed to OxyCure Therapy in isolation, consistent with the clinic’s position that the therapy supports the healing environment rather than driving density on its own (Vera Clinic Academy Database, 2026).

Accreditations

Frequently Asked Questions: OxyCure Therapy

Sources and Citations

Medical Authorities

U.S. Food and Drug Administration. Hyperbaric Oxygen Therapy: Get the Facts. 2021. https://www.fda.gov/consumers/consumer-updates/hyperbaric-oxygen-therapy-get-facts. Accessed June 2026.

Undersea and Hyperbaric Medical Society. Hyperbaric Oxygen Therapy Indications. 2023. https://www.uhms.org/resources/featured-resources/hbo-indications.html. Accessed June 2026.

Clinical Studies

Francis A, Baynosa RC. Hyperbaric Oxygen Therapy for the Compromised Graft or Flap. Advances in Wound Care (New Rochelle). 2017;6(1):23-32. https://pmc.ncbi.nlm.nih.gov/articles/PMC5220535/. Accessed June 2026.

Perrins DJD. Influence of Hyperbaric Oxygen on the Survival of Split Skin Grafts. J Surg Res. 1967;7:583-586.

Jones MW, Cooper JS. Hyperbaric Therapy for Skin Grafts and Flaps. StatPearls. Treasure Island (FL): StatPearls Publishing; 2026. PMID: 29262046.

Market Reports

Mordor Intelligence. Hyperbaric Oxygen Therapy Market Size, Share and Trends. 2026. https://www.mordorintelligence.com/industry-reports/hyperbaric-oxygen-therapy. Accessed June 2026.

Fortune Business Insights. Hyperbaric Oxygen Therapy Market Size, Share & Industry Analysis. 2026. https://www.fortunebusinessinsights.com/industry-reports/hyperbaric-oxygen-therapy-market-101103. Accessed June 2026.

Clinical Database and Clinic Sources

Vera Clinic. OxyCure Therapy (Hyperbaric Oxygen Therapy) After Hair Transplant. 2026. https://www.veraclinic.net/oxycure-therapy/. Accessed June 2026.

Vera Clinic. Hair Transplant Turkey Cost 2026. 2026. https://www.veraclinic.net/hair-transplant-turkey-cost/. Accessed June 2026.

Vera Clinic Academy Database. Internal clinical database of procedural, operational, and outcome data. Istanbul, Turkey. 2026. Referenced throughout as (Vera Clinic Academy Database, 2026). Accessed June 2026.

Version Log

Next review: September 2026.